NovoCure Limited (NVCR)
NASDAQ: NVCR · IEX Real-Time Price · USD
23.15
+0.84 (3.77%)
At close: May 24, 2024, 4:00 PM
23.16
+0.01 (0.04%)
After-hours: May 24, 2024, 7:35 PM EDT

NovoCure Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018 - 2013
Revenue
509.34537.84535.03494.37351.32
Upgrade
Revenue Growth (YoY)
-5.30%0.53%8.23%40.72%41.62%
Upgrade
Cost of Revenue
128.28114.87114.88106.588.61
Upgrade
Gross Profit
381.06422.97420.15387.87262.71
Upgrade
Selling, General & Admin
390.87306.41263.18225.45184.62
Upgrade
Research & Development
223.06206.09201.3132.0179
Upgrade
Operating Expenses
613.93512.5464.49357.46263.63
Upgrade
Operating Income
-232.87-89.52-44.3330.4-0.91
Upgrade
Interest Expense / Income
-41.13-7.687.7412.37.91
Upgrade
Pretax Income
-191.74-81.85-52.0818.1-8.82
Upgrade
Income Tax
15.310.696.28-1.71-1.59
Upgrade
Net Income
-207.04-92.53-58.3519.81-7.23
Upgrade
Shares Outstanding (Basic)
10610510310197
Upgrade
Shares Outstanding (Diluted)
10610510310997
Upgrade
Shares Change
1.65%1.19%-5.00%11.97%5.89%
Upgrade
EPS (Basic)
-1.95-0.88-0.560.20-0.07
Upgrade
EPS (Diluted)
-1.95-0.88-0.560.18-0.07
Upgrade
Free Cash Flow
-100.439.4358.5984.1816.14
Upgrade
Free Cash Flow Per Share
-0.940.090.570.830.17
Upgrade
Gross Margin
74.81%78.64%78.53%78.46%74.78%
Upgrade
Operating Margin
-45.72%-16.64%-8.29%6.15%-0.26%
Upgrade
Profit Margin
-40.65%-17.20%-10.91%4.01%-2.06%
Upgrade
Free Cash Flow Margin
-19.72%1.75%10.95%17.03%4.59%
Upgrade
Effective Tax Rate
----9.42%-
Upgrade
EBITDA
-221.9-78.9-34.0839.557.55
Upgrade
EBITDA Margin
-43.57%-14.67%-6.37%8.00%2.15%
Upgrade
Depreciation & Amortization
10.9710.6210.259.158.46
Upgrade
EBIT
-232.87-89.52-44.3330.4-0.91
Upgrade
EBIT Margin
-45.72%-16.64%-8.29%6.15%-0.26%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).